Bank of America
SBIO icon

Bank of America’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bank of America’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.16M Buy
98,679
+38,193
+63% +$1.94M ﹤0.01% 3441
2025
Q4 		$3.1M Buy
60,486
+9,596
+19% +$444K ﹤0.01% 3729
2025
Q3 		$1.98M Sell
50,890
-2,857
-5% -$98.2K ﹤0.01% 4831
2025
Q2 		$1.62M Sell
53,747
-85,952
-62% -$2.46M ﹤0.01% 4946
2025
Q1 		$3.98M Buy
139,699
+7,468
+6% +$236K ﹤0.01% 4045
2024
Q4 		$4.37M Buy
132,231
+13,658
+12% +$515K ﹤0.01% 3723
2024
Q3 		$4.43M Buy
118,573
+2,193
+2% +$80K ﹤0.01% 3848
2024
Q2 		$3.91M Sell
116,380
-48,930
-30% -$1.64M ﹤0.01% 3849
2024
Q1 		$5.91M Buy
165,310
+13,394
+9% +$464K ﹤0.01% 3458
2023
Q4 		$5M Buy
151,916
+28,253
+23% +$759K ﹤0.01% 3555
2023
Q3 		$3.37M Sell
123,663
-2,490
-2% -$75K ﹤0.01% 3770
2023
Q2 		$3.98M Sell
126,153
-4,182
-3% -$130K ﹤0.01% 3615
2023
Q1 		$3.54M Buy
130,335
+20,892
+19% +$631K ﹤0.01% 3846
2022
Q4 		$3.32M Sell
109,443
-1,599
-1% -$48.1K ﹤0.01% 3787
2022
Q3 		$3.35M Sell
111,042
-67,425
-38% -$2.13M ﹤0.01% 3780
2022
Q2 		$4.94M Sell
178,467
-4,071
-2% -$116K ﹤0.01% 3408
2022
Q1 		$6.14M Buy
182,538
+7,292
+4% +$253K ﹤0.01% 3401
2021
Q4 		$7.4M Sell
175,246
-24,136
-12% -$1.08M ﹤0.01% 3259
2021
Q3 		$9.07M Sell
199,382
-5,453
-3% -$250K ﹤0.01% 2961
2021
Q2 		$10M Buy
204,835
+138
+0.1% +$6.61K ﹤0.01% 2862
2021
Q1 		$10.3M Buy
204,697
+4,948
+2% +$274K ﹤0.01% 2691
2020
Q4 		$10.2M Buy
199,749
+7,675
+4% +$365K ﹤0.01% 2467
2020
Q3 		$7.9M Sell
192,074
-6,788
-3% -$280K ﹤0.01% 2479
2020
Q2 		$8.32M Buy
198,862
+17,501
+10% +$690K ﹤0.01% 2382
2020
Q1 		$5.75M Sell
181,361
-3,771
-2% -$144K ﹤0.01% 2544
2019
Q4 		$7.83M Sell
185,132
-21,218
-10% -$787K ﹤0.01% 2805
2019
Q3 		$6.51M Buy
206,350
+19,428
+10% +$683K ﹤0.01% 2947
2019
Q2 		$6.75M Buy
186,922
+2,405
+1% +$82.9K ﹤0.01% 2934
2019
Q1 		$6.68M Buy
184,517
+15,900
+9% +$531K ﹤0.01% 2874
2018
Q4 		$4.75M Sell
168,617
-253,050
-60% -$8.39M ﹤0.01% 3043
2018
Q3 		$16.6M Buy
421,667
+9,674
+2% +$367K ﹤0.01% 2005
2018
Q2 		$15.4M Buy
411,993
+154,488
+60% +$5.6M ﹤0.01% 2049
2018
Q1 		$8.81M Buy
257,505
+107,864
+72% +$3.78M ﹤0.01% 2527
2017
Q4 		$4.91M Buy
149,641
+16,968
+13% +$531K ﹤0.01% 3143
2017
Q3 		$4.14M Buy
132,673
+5,868
+5% +$172K ﹤0.01% 3351
2017
Q2 		$3.53M Buy
126,805
+22,645
+22% +$589K ﹤0.01% 3365
2017
Q1 		$2.68M Sell
104,160
-20,427
-16% -$508K ﹤0.01% 3607
2016
Q4 		$2.85M Sell
124,587
-39,927
-24% -$956K ﹤0.01% 3456
2016
Q3 		$4.29M Buy
164,514
+28,259
+21% +$705K ﹤0.01% 2958
2016
Q2 		$3.08M Buy
136,255
+3,687
+3% +$87.6K ﹤0.01% 3237
2016
Q1 		$2.91M Sell
132,568
-8,692
-6% -$199K ﹤0.01% 3254
2015
Q4 		$4.49M Buy
141,260
+79,100
+127% +$2.42M ﹤0.01% 3055
2015
Q3 		$1.73M Sell
62,160
-10,620
-15% -$371K ﹤0.01% 3894
2015
Q2 		$2.59M Buy
72,780
+59,105
+432% +$1.93M ﹤0.01% 3210
2015
Q1 		$409K Buy
+13,675
New +$385K ﹤0.01% 4454

Other funds holding SBIO

Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CIS
Connors Investor Services Wyomissing, Pennsylvania $1.08B AUM 31.31% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
MWM
Moran Wealth Management Naples, Florida $3.27B AUM 25.8% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

Bank of America's SBIO Position: Q1 2026 in Review

Bank of America increased its ALPS Medical Breakthroughs ETF (SBIO) stake by 63% in Q1 2026, buying an estimated $1.94M and bringing the position to 98,679 shares worth $5.16M. The position accounts for ﹤0.01% of the portfolio, ranked #3441.

Bank of America first reported a position in SBIO in Q1 2015 and has held it in 45 quarters since. The position peaked at $16.6M in Q3 2018. 59 funds tracked by Wall St. Rank hold SBIO as of Q1 2026.

  • Bank of America held 98,679 shares of ALPS Medical Breakthroughs ETF worth $5.16M as of Q1 2026.
  • Bank of America bought 38,193 ALPS Medical Breakthroughs ETF shares in Q1 2026, an estimated $1.94M.
  • ALPS Medical Breakthroughs ETF made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3441 holding.
  • Bank of America first reported a position in ALPS Medical Breakthroughs ETF in Q1 2015 and has held it in 45 quarters since.
  • Bank of America's ALPS Medical Breakthroughs ETF position peaked at $16.6M in Q3 2018.
  • 59 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.